Literature DB >> 8837099

MRI in the mild type of mucopolysaccharidosis II (Hunter's syndrome).

N Shinomiya1, T Nagayama, Y Fujioka, T Aoki.   

Abstract

We report imaging findings in a 3-year-old boy with the typical mild type of Hunter's disease. MRI revealed multifocal large cyst- or spindle-like areas of increased and decreased signal in the white matter, including the corpus callosum on T1- and T2-weighted images. The white matter showed high signal on T2-weighted images, isointense with cerebrospinal fluid on all other pulse sequences. To our knowledge, these appearances have not been reported in this disorder. Deposition of mucopolysaccharide and/or glycolipid and increase in fluid content seem to be responsible.

Entities:  

Mesh:

Year:  1996        PMID: 8837099     DOI: 10.1007/bf00607284

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

Review 1.  The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment.

Authors:  J J Hopwood; C P Morris
Journal:  Mol Biol Med       Date:  1990-10

2.  Large Virchow-Robin spaces: MR-clinical correlation.

Authors:  L A Heier; C J Bauer; L Schwartz; R D Zimmerman; S Morgello; M D Deck
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

3.  MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome).

Authors:  S Shimoda-Matsubayashi; Y Kuru; H Sumie; T Ito; N Hattori; Y Okuma; Y Mizuno
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

4.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  MR imaging of the brain in patients with mucopolysaccharidosis.

Authors:  R Murata; S Nakajima; A Tanaka; N Miyagi; O Matsuoka; S Kogame; Y Inoue
Journal:  AJNR Am J Neuroradiol       Date:  1989 Nov-Dec       Impact factor: 3.825

6.  Cerebral MRI in two brothers with mucopolysaccharidosis type I and different clinical phenotypes.

Authors:  O Gabrielli; U Salvolini; M Maricotti; M G Mariani; G V Coppa; P L Giorgi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.

Authors:  P J Wilson; G K Suthers; D F Callen; E Baker; P V Nelson; A Cooper; J E Wraith; G R Sutherland; C P Morris; J J Hopwood
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

8.  Cranial computed tomography in disorders of complex carbohydrate metabolism and related storage diseases.

Authors:  B Ludwig; T Kishikawa; S Wende; M Rochel; J Gehler
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

9.  Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.

Authors:  A S Dekaban; G Constantopoulos
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

10.  Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses.

Authors:  M V Kulkarni; J C Williams; J W Yeakley; J L Andrews; C B McArdle; P A Narayana; R R Howell; A J Jonas
Journal:  Magn Reson Imaging       Date:  1987       Impact factor: 2.546

  10 in total
  7 in total

1.  Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation.

Authors:  M Gisele Matheus; Mauricio Castillo; J Keith Smith; Diane Armao; Diane Towle; Joseph Muenzer
Journal:  Neuroradiology       Date:  2004-06-17       Impact factor: 2.804

Review 2.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

3.  Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy.

Authors:  Renzo Manara; Elena Priante; Marco Grimaldi; Lucia Santoro; Luca Astarita; Rita Barone; Daniela Concolino; Maja Di Rocco; Maria Alice Donati; Simona Fecarotta; Anna Ficcadenti; Agata Fiumara; Francesca Furlan; Irene Giovannini; Franco Lilliu; Rodica Mardari; Gabriele Polonara; Elena Procopio; Angelica Rampazzo; Andrea Rossi; Graziolina Sanna; Rossella Parini; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2011-04-05       Impact factor: 4.982

Review 4.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

5.  Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution.

Authors:  Renzo Manara; Angelica Rampazzo; Mara Cananzi; Leonardo Salviati; Rodica Mardari; Paola Drigo; Rosella Tomanin; Nicoletta Gasparotto; Elena Priante; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-01-06       Impact factor: 4.982

Review 6.  Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Authors:  J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman
Journal:  Eur J Pediatr       Date:  2007-11-23       Impact factor: 3.183

7.  Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).

Authors:  Molly Stapleton; Francyne Kubaski; Robert W Mason; Hiromasa Yabe; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-08       Impact factor: 0.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.